e-Article

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	あ a	ぁ	か ka	が ga	さ sa	ざ za	た ta	だ da		な na	は ha	ば ba	ぱ pa	ま ma	や ya	ゃ lya	ら ra	わ wa	ゎ lwa	ん n
l	い i	ぃ	き ki	ぎ gi	し si	じ zi	ち ti	ぢ di		に ni	ひ hi	び bi	ぴ pi	み mi			り ri
ㅜ	う u	ぅ	く ku	ぐ gu	す su	ず zu	つ tu	づ du	っ	ぬ nu	ふ hu	ぶ bu	ぷ pu	む mu	ゆ yu	ゅ lyu	る ru
ㅔ	え e	ぇ	け ke	げ ge	せ se	ぜ ze	て te	で de		ね ne	へ he	べ be	ぺ pe	め me			れ re
ㅗ	お o	ぉ	こ ko	ご go	そ so	ぞ zo	と to	ど do		の no	ほ ho	ぼ bo	ぽ po	も mo	よ yo	ょ lyo	ろ ro	を wo

	o	ㅋ	ㄱ	ㅅ	ㅈ	ㅌ	ㄷ	촉	ㄴ	ㅎ	ㅂ	ㅃ	ㅁ	야	ㄹ	와
ㅏ	ア a	ァ	カ ka	ガ ga	サ sa	ザ za	タ ta	ダ da		ナ na	ハ ha	バ ba	パ pa	マ ma	ヤ ya	ャ lya	ラ ra	ワ wa	ヮ lwa		ン n
l	イ i	ィ	キ ki	ギ gi	シ si	ジ zi	チ ti	ヂ di		ニ ni	ヒ hi	ビ bi	ピ pi	ミ mi			リ ri
ㅜ	ウ u	ゥ	ク ku	グ gu	ス su	ズ zu	ツ tu	ヅ du	ッ	ヌ nu	フ hu	ブ bu	プ pu	ム mu	ユ yu	ュ lyu	ル ru			ヴ vu
ㅔ	エ e	ェ	ケ ke	ゲ ge	セ se	ゼ ze	テ te	デ de		ネ ne	ヘ he	ベ be	ぺ pe	メ me			レ re
ㅗ	オ o	ォ	コ ko	ゴ go	ソ so	ゾ zo	ト to	ド do		ノ no	ホ ho	ボ bo	ポ po	モ mo	ヨ yo	ョ lyo	ロ ro	ヲ wo		ーー

독일어
ä	Ä	ö	Ö	ü	Ü	ß
프랑스어
á	à	Á	À	é	è	É	È	ç	Ç	ê
스페인어
à	á	Á	é	É	í	Í	Ó	ó	Ú	ú	Ñ	ñ	ä	Ä

Publication date	- (ex : 2010-2015)

Select All

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

Academic Journal

Asfar, Pierre; Nay, Mai-Anh; Guitton, Christophe; Quenot, Jean-Pierre; Tran-Van, David; Bohe, Julien; Plantefève, Gaëtan; Nseir, Saadalla; Lefrant, Jean-Yves; Monnet, Xavier; Papazian, Laurent; Vinsonneau, Christophe; Constantin, Jean-Michel; Mebazaa, Alexandre; Oueslati, Haikel; Escudero, Dolores; Martinez Sagasti, Fernando; Piacentini, Enrique; Ramirez Galleymore, Paula; Dugernier, Thierry; Fagnoul, David; Michaux, Isabelle; Seibert, Allan; Reinikainen, Matti; Grøfte, Thorbjørn; Martin-Loeches, Ignacio; Laffey, John; François, Bruno ; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarié, Jérémie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valérie; Ferrer, Ricard; Bestle, Morten; Pettilä, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris; Huberlant, Vincent; Vinatier, Isabelle; Anguel, Nadia; Levy, Mitchell; Laterre, Pierre-François

In The Lancet Respiratory Medicine October 2023 11(10):894-904

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

Academic Journal

François, Bruno; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarié, Jérémie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valérie; Ferrer, Ricard; Bestle, Morten; Pettilä, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris

Lancet Respiratory Medicine; Oct2023, Vol. 11 Issue 10, p894-904, 11p

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, aTREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

Academic Journal

Francois, Bruno; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarie, Jeremie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valerie; Ferrer, Ricard; Bestle, Morten; Pettila, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris; Huberlant, Vincent; Vinatier, Isabelle; Anguel, Nadia; Levy, Mitchell; Laterre, Pierre-Francois; ASTONISH Invest

LANCET RESPIRATORY MEDICINE; OCT 2023, 11 10, p894-p904, 11p.

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Web of Science JCR 저널정보 Scopus Find it@PNU

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH):a double-blind, randomised, controlled, phase 2b trial

Electronic Resource

François, Bruno; Lambden, Simon; Fivez, Tom; Gibot, Sebastien; Derive, Marc; Grouin, Jean-Marie; Salcedo-Magguilli, Margarita; Lemarié, Jérémie; De Schryver, Nicolas; Jalkanen, Ville; Hicheur, Tarik; Garaud, Jean-Jacques; Cuvier, Valérie; Ferrer, Ricard; Bestle, Morten; Pettilä, Ville; Mira, Jean-Paul; Bouisse, Camille; Mercier, Emmanuelle; Vermassen, Joris; Huberlant, Vincent; Vinatier, Isabelle; Anguel, Nadia; Levy, Mitchell; Laterre, Pierre François

François , B , Lambden , S , Fivez , T , Gibot , S , Derive , M , Grouin , J-M , Salcedo-Magguilli , M , Lemarié , J , De Schryver , N , Jalkanen , V , Hicheur , T , Garaud , J-J , Cuvier , V , Ferrer , R , Bestle , M , Pettilä , V , Mira , J-P , Bouisse , C , Mercier , E , Vermassen , J , Huberlant , V , Vinatier , I , Anguel , N , Levy , M , Laterre , P F & ASTONISH investigators 2023 , ' Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial ' , The Lancet Respiratory Medicine , vol. 11 , no. 10 , pp. 894-904 .

Open Access (OAIster)

부산대학교 도서관

Send an e-mail